Verona Pharma Market & Company News

06.11.2018 07:00 Verona Pharma plc Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018 GNW
31.10.2018 07:00 Verona Pharma plc Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment GNW
30.10.2018 06:00 Verona Pharma plc Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update GNW
26.10.2018 10:12 Verona Pharma plc Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference GNW
20.09.2018 17:50 Verona Pharma PLC Director Deals - Verona Pharma PLC (VRP) SMW
10.08.2018 13:20 Verona Pharma PLC Director Deals - Verona Pharma PLC (VRP) SMW
07.08.2018 09:30 Verona Pharma PLC Verona Pharma losses deepen as finance costs rise SMW
01.08.2018 07:00 Verona Pharma plc Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment GNW
26.07.2018 13:30 Verona Pharma plc Verona Pharma plc : Notice of Results GNW
24.07.2018 13:30 Verona Pharma plc Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference GNW
26.06.2018 17:22 Verona Pharma plc Verona Pharma plc : Result of General Meeting of Shareholders GNW
04.06.2018 07:00 Verona Pharma plc Verona Pharma's Shelf Registration Statement declared effective by SEC GNW
31.05.2018 07:00 Verona Pharma plc Verona Pharma plc : Block Listing Update GNW
30.05.2018 13:30 Verona Pharma plc Verona Pharma to Present at Upcoming Investor Conferences GNW
23.05.2018 07:00 Verona Pharma plc Verona Pharma Files Shelf Registration Statement with SEC GNW
22.05.2018 07:03 Verona Pharma plc Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD GNW
09.05.2018 13:30 Verona Pharma plc Verona Pharma plc : Miscellaneous GNW
08.05.2018 10:50 Verona Pharma PLC Broker Forecast - Shore Capital issues a broker note on Verona Pharma PLC SMW
08.05.2018 07:00 Verona Pharma plc Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018 GNW
04.05.2018 13:30 Verona Pharma plc Verona Pharma to Present at Bio€quity Europe 2018 GNW
03.05.2018 08:31 Verona Pharma plc Verona Pharma plc : Result of AGM GNW
02.05.2018 13:30 Verona Pharma plc Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018 GNW
11.04.2018 13:42 Verona Pharma PLC Verona Pharma chief medical officer Kenneth Newman to leave SMW
11.04.2018 11:10 Verona Pharma PLC Broker Forecast - Shore Capital issues a broker note on Verona Pharma PLC SMW
11.04.2018 07:00 Verona Pharma plc Verona Pharma Announces Departure of Chief Medical Officer GNW
26.03.2018 07:00 Verona Pharma plc Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD GNW
21.03.2018 13:10 Verona Pharma PLC Broker Forecast - N+1 Singer issues a broker note on Verona Pharma PLC SMW
15.03.2018 12:00 Verona Pharma plc Verona Pharma to Present at Upcoming Healthcare Investor Conferences GNW
09.03.2018 17:30 Verona Pharma plc Verona Pharma plc: 2017 Annual Report and Accounts and Notice of AGM GNW
09.03.2018 14:24 Verona Pharma plc Verona Pharma plc : Grant of Options and RSUs and PDMR Dealings GNW
08.03.2018 13:38 Verona Pharma plc Verona Pharma plc : 1st Quarter Results GNW
02.03.2018 16:40 Verona Pharma PLC Second Price Monitoring Extn RNS
02.03.2018 16:35 Verona Pharma PLC Price Monitoring Extension RNS
02.03.2018 13:46 Verona Pharma PLC Verona Pharma welcomes trial results for cystic fibrosis treatment SMW
02.03.2018 07:00 Verona Pharma plc Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients GNW
27.02.2018 07:00 Verona Pharma plc Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017 GNW
22.02.2018 13:45 Verona Pharma plc Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017 GNW
13.02.2018 13:05 Verona Pharma PLC Verona Pharma expects to report treatment trial data ahead of schedule SMW
13.02.2018 12:35 Verona Pharma plc Verona Pharma Provides Clinical Development Update GNW
30.11.2017 18:52 Verona Pharma plc Verona Pharma plc : Block listing Interim Review GNW
30.11.2017 14:45 Verona Pharma PLC Director Deals - Verona Pharma PLC (VRP) SMW
30.11.2017 13:56 Verona Pharma plc Verona Pharma plc : PDMR Dealing GNW
27.11.2017 11:40 Verona Pharma PLC Broker Forecast - N+1 Singer issues a broker note on Verona Pharma PLC SMW
07.11.2017 09:15 Verona Pharma PLC Verona Pharma losses deepen SMW
07.11.2017 07:00 Verona Pharma plc Verona Pharma plc Operational Update and Financial Results for the Third Quarter Ended September 30, 2017 GNW
07.11.2017 07:00 Verona Pharma plc Verona Pharma Reports Patient Enrollment Progressing Ahead of Schedule in Ongoing Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment GNW
31.10.2017 07:00 Verona Pharma plc Verona Pharma to Announce Operational Update and Financial Results for the Third Quarter Ended September 30, 2017 GNW
31.10.2017 06:55 Verona Pharma plc Verona Pharma to Present at Two Upcoming Investor Conferences GNW
02.10.2017 07:00 Verona Pharma plc Verona Pharma plc : Total voting rights GNW
27.09.2017 07:00 Verona Pharma plc Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients GNW
Showing 1 to 50 of 509